Bacterial resistance to antibiotics used in treatment of gonorreia: a literature review
DOI:
https://doi.org/10.33448/rsd-v10i3.13127Keywords:
Antibacterial drug resistance; Neisseria gonorrhoeae infection; Sexually transmitted diseases; Prevalence.Abstract
Gonorrhea is a sexually transmitted infections that is among the most common public health problems worldwide. This disease is caused by the gram-negative bacterium Neisseria gonorrhoeae, which is a microorganism restricted to humans. Since it presents itself as a frequent infection, N. gonorrhoeae shows an extraordinary ability to develop resistance to multiple classes of antibiotics, becoming extremely important, besides worrying public health authorities. Therefore, the objective of this work was to present a survey about the main antibiotics associated with resistance attributed to N. gonorrhoeae, according to scientific publications presented in 2017 and 2018, in different databases (Scielo, PubMed, Lilacs and Google Scholar). Through an integrative literature review, using terms according to the Health Descriptors - DeCS, articles were found based on national and international data that had a close relationship with the proposed theme. They were selected for data analysis and description, thus allowing an understanding of the problem presented. Antibiotic resistance by N. gonorrhoeae strains is found to be widespread worldwide. It is clear that ceftriaxone, cefixime, cefotaxime, penicillins, tetracyclines and macrolide derivatives are no longer effective in treating infections caused by this microorganism. Findings warn of this serious public health problem.
References
Beceiro, A., Tomás, M., & Bou, G. (2013). Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clinical microbiology reviews, 26(2), 185-230.
Britto, A. M. A., Policarpo, C., Pezzuto, P., Meirelles, A. R. I., Furtado, Y. L., Almeida, G., ... & Machado, E. S. (2018). Detection of sexually transmitted infections at a Brazilian gynecology center: high prevalence of co-infections. Jornal Brasileiro de Patologia e Medicina Laboratorial, 54(6), 393-400.
Buder, S., Dudareva, S., Jansen, K., Loenenbach, A., Nikisins, S., Sailer, A. Guhl, E , Kohl, P, K , Bremer, V & GORENET S, G. (2018). Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infectious Diseases, 18(1), 44.
Clifton, S., Bolt, H., Mohammed, H., Town, K., Furegato, M., Cole, M., Campbell, O, Fifer, H & Hughes, G. (2018). Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys. Journal of Antimicrobial Chemotherapy, 73(4), 923-932.
Cole, M. J., Spiteri, G., Jacobsson, S., Woodford, N., Tripodo, F., Amato-Gauci, A. J., & Unemo, M. (2017). Overall low extended-spectrum cephalosporin resistance but high azithromycin resistance in Neisseria gonorrhoeae in 24 European countries, 2015. BMC infectious diseases, 17(1), 617.
Da Costa-Lourenço, A. P. R., Abrams, A. J., Dos Santos, K. T. B., Argentino, I. C. V., Coelho-Souza, T., Caniné, M. C. A., Ferreira, A, L, P, Moreira, B, M, Fracalanzza, S, E, L, Árvores, D, L & Bonelli, R. R. (2018). Phylogeny and antimicrobial resistance in Neisseria gonorrhoeae isolates from Rio de Janeiro, Brazil. Infection, Genetics and Evolution, 58, 157-163.
Da Costa, A. L. P., & Junior, A. C. S. S. (2017). Resistência bacteriana aos antibióticos e Saúde Pública: uma breve revisão de literatura. Estação Científica (UNIFAP), 7(2), 45-57.
Day, M. J., Spiteri, G., Jacobsson, S., Woodford, N., Amato-Gauci, A. J., Cole, M. J., & Unemo, M. (2018). Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016. BMC Infectious Diseases, 18(1), 1-8.
Eyre, D. W., Sanderson, N. D., Lord, E., Regisford-Reimmer, N., Chau, K., Barker, L., Morgan, M , Newnham, R , Golparian, D , Unemo, M , Crook, D, W, Peto, T, E, A , Hughes, G , Cole, M, J , Fifer, H , Edwards, A & Andersson, M. I. (2018). Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eurosurveillance, 23(27), 1800323.
Freitas, G. D., de Lima, C. P., Coelho, D. F. S., Moraes, M. O., Lima, G. L., & Alves, W. R. (2021). Uso de diferentes métodos no controle do desenvolvimento do Staphylococcus aureus: uma revisão da literatura. Research, Society and Development, 10(2).
os planos das Comissões, V. (2018). N. gonorrhoeae no Brasil e no mundo. Femina, 46(1).
García, D. S. D., Casco, R. H., Losada, M. O., Perazzi, B. E., Vay, C. A., & Famiglietti, Á. M. R. (2016). Estado actual de la gonorrea. Revista de la Asociación Médica Argentina, 129(2).
Harris, S. R., Cole, M. J., Spiteri, G., Sánchez-Busó, L., Golparian, D., Jacobsson, S., Goater, R, Abudahab, K., Yeats, C, A., Bercot, B., Borrego, M, J., Crowley, B., Paola Stefanelli, P., Tripodo, F., Abad, R., Aanensen, D, M., Unemo, M & Verbrugge, R. (2018). Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey. The Lancet Infectious diseases, 18(7), 758-768.
Jiang, F. X., Lan, Q., Le, W. J., & Su, X. H. (2017). Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014–2015): genetic characteristics of antimicrobial resistance. BMC infectious diseases, 17(1), 366.
Kapoor, G., Saigal, S., & Elongavan, A. (2017). Action and resistance mechanisms of antibiotics: A guide for clinicians. Journal of anaesthesiology, clinical pharmacology, 33(3), 300.
Kularatne, R., Maseko, V., Gumede, L., & Kufa, T. (2018). Trends in Neisseria gonorrhoeae antimicrobial resistance over a ten-year surveillance period, Johannesburg, South Africa, 2008–2017. Antibiotics, 7(3), 58.
Landig, C. S., Hazel, A., Kellman, B. P., Fong, J. J., Schwarz, F., Agarwal, S., Varki, N., Massari, P., Lewis, N, E., Ram, S & Varki, A. (2019). Evolution of the exclusively human pathogen Neisseria gonorrhoeae: Human‐specific engagement of immunoregulatory Siglecs. Evolutionary applications, 12(2), 337-349.
Lee, R. S., Seemann, T., Heffernan, H., Kwong, J. C., Gonçalves da Silva, A., Carter, G. P., Woodhouse, R., Dyet, K, H., Bulach, D, M., Stinear, T, P., Howden, B, P., Williamson, D. A. (2018). Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. Journal of Antimicrobial Chemotherapy, 73(2), 353-364.
Lima, D. M., da Silva, A. B. P., de Souza, R. R. P., da Costa Prado, N. C., Jales, A. K. F. A., & da Silva, R. A. R. (2020). As infecções sexualmente transmissíveis e o impacto na transmissão vertical: uma revisão integrativa. Research, Society and Development, 9(7).
Loureiro, R. J., Roque, F., Rodrigues, A. T., Herdeiro, M. T., & Ramalheira, E. (2016). O uso de antibióticos e as resistências bacterianas: breves notas sobre a sua evolução. Revista Portuguesa de saúde pública, 34(1), 77-84.
Mendes-Bastos, P., Brito, H. T., Rodrigues, I., Pina, T., Fernandes, C., Rodrigues, A., & Cardoso, J. (2015). Infecção por neisseria gonorrhoeae na consulta de IST do hospital de Curry Cabral–análise retrospectiva de 8 anos (2006-2013). Journal of the Portuguese Society of Dermatology and Venereology, 73(2), 267-273.
Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, M. C. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto contexto –enferm,28 (e20170204)
Mota, R. A., da Silva, K. P. C., de Freitas, M. F. L., Porto, W. J. N., & da Silva, L. B. G. (2005). Utilização indiscriminada de antimicrobianos e sua contribuição a multirresitência bacteriana. Brazilian Journal of Veterinary Research and Animal Science, 42(6), 465-470.
Papp, J. R., Abrams, A. J., Nash, E., Katz, A. R., Kirkcaldy, R. D., O’Connor, N. P., O'Brien, P, S., Harauchi, D, H., Maningas, E, V., O’Soge, O., Ellen N. Kersh, E, N., Komeya, A., Tomas, J, E., Wasserman, G, M., Kunimoto, G, Y., David L. Trees, D, L e A., Whelenautor, C (2017). Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA. Emerging infectious diseases, 23(5), 830.
Peng, T., Lin, H., Liu, Q., Cao, W., Ding, H., Chen, J., & Tang, L. (2017). Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China. Journal of Infection and Chemotherapy, 23(6), 385-389.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Ed. Santa Maria, RS: UFSM, NTE.
Poncin, T., Fouere, S., Braille, A., Camelena, F., Agsous, M., Bebear, C., Kumanski, S., Lot, F., Delarue, S, M., Ngangro, N, N., Salmona, M., Schnepf, N., Timsit, J., Unemo, M & Bercot, B. (2018). Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Eurosurveillance, 23(21), 1800264.
Ryan, L., Golparian, D., Fennelly, N., Rose, L., Walsh, P., Lawlor, B., B. Lawlor., Aogáin, M, M., M. Unemo & Crowley, B. (2018). Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014–2016: focus on extended-spectrum cephalosporins and azithromycin. European Journal of Clinical Microbiology & Infectious Diseases, 37(9), 1661-1672.
Salvo, L. A. (2011). Infecciones de transmisión sexual (ITS) en chile. Revista Médica Clínica Las Condes, 22(6), 813-824.
Santos, L. A., Izidoro, T. C. R., Silvério, A. D. S. D., & Messora, L. B. (2015). Avaliação do conhecimento de adultos e adolescentes sobre doenças sexualmente transmissíveis-DSTs. Adolescencia e Saude, 12(1), 23-27.
Serra-Pladevall, J., Barberá-Gracia, M. J., Roig-Carbajosa, G., Juvé-Saumell, R., Gonzalez-Lopez, J. J., Bartolomé-Comas, R., & Andreu-Domingo, A. (2013). Neisseria gonorrhoeae: resistencias antimicrobianas y estudio de la dinámica poblacional. Situación en 2011 en Barcelona. Enfermedades Infecciosas Y Microbiología Clínica, 31(9), 579-583.
Silva, M. O. D., & Aquino, S. (2018). Resistência aos antimicrobianos: uma revisão dos desafios na busca por novas alternativas de tratamento. Rev. epidemiol. controle infecç, 472-482.
Sood, S., Agarwal, M., Bala, M., Mahajan, N., Singh, R., Kapil, A., Sreenivas, V., Ram, R, J., Kar, H, K & Sharma, V. K. (2017). Exploring quinolone resistance-determining region in Neisseria gonorrhoeae isolates from across India. The Indian Journal of Medical Research, 146(Suppl 1), S64.
Ratti, R. P., & Sousa, C. P. (2009). Staphylococcus aureus meticilina resistente (MRSA) e infecções nosocomiais. Journal of Basic and Applied Pharmaceutical Sciences, 30(2).
Oliveira S, D., Relison T, S., Gomes F, F., Melo B, M, C., Bezerra M, B, M, F., Bezerra F, C, F., Martins C, J, G., Melo C, H, D., Alencar M, I, R., Kerntopf M, R. (2014). Actividad antibacteriana y moduladora de Cecropia pachystachya Trécul en la acción de los aminoglucósidos. Revista Cubana de Plantas Medicinales, 19(3), 121-132.
Tavares, W. (2014). Antibióticos e quimioterápicos para o clínico. Atheneu.
Terkelsen, D., Tolstrup, J., Johnsen, C. H., Lund, O., Larsen, H. K., Worning, P., Unemo, M & Westh, H. (2017). Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Eurosurveillance, 22(42), 17-00659.
Tomberg, J., Fedarovich, A., Vincent, L. R., Jerse, A. E., Unemo, M., Davies, C., & Nicholas, R. A. (2017). Alanine 501 mutations in penicillin-binding protein 2 from Neisseria gonorrhoeae: structure, mechanism, and effects on cephalosporin resistance and biological fitness. Biochemistry, 56(8), 1140-1150.
De Vega, I. F., Baliu-Piqué, C., Mestres, J. B., Gómez, A. V., Vallés, X., & Gibert, M. A. (2018). Risk factors for antimicrobial-resistant Neisseria gonorrhoeae and characteristics of patients infected with gonorrhea. Enfermedades Infecciosas y Microbiología Clínica, 36(3), 165-168.
Venter, J. M., Mahlangu, P. M., Müller, E. E., Lewis, D. A., Rebe, K., Struthers, H., McIntyre, J. & Kularatne, R. S. (2019). Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens. BMC infectious diseases, 19(1), 6.
Vigue, L., & Eyre-Walker, A. (2019). The comparative population genetics of Neisseria meningitidis and Neisseria gonorrhoeae. PeerJ, 7, e7216.
Wan, C., Li, Y., Le, W. J., Liu, Y. R., Li, S., Wang, B. X., Rice, P, A. & Su, X. H. (2018). Increasing resistance to azithromycin in Neisseria gonorrhoeae in eastern Chinese cities: resistance mechanisms and genetic diversity among isolates from Nanjing. Antimicrobial agents and chemotherapy, 62(5).
Whiley, D. M., Kundu, R. L., Jennison, A. V., Buckley, C., Limnios, A., Hogan, T., Enriquez, R., Nasser, J, E., George, C, R. & Lahra, M. M. (2018). Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017. Journal of Antimicrobial Chemotherapy, 73(5), 1242-1246.
Whiley, D. M., Trembizki, E., Buckley, C., Freeman, K., Baird, R. W., Beaman, M., Chen, M., Donovan, B., Kundu, R, L., Fairley, C, K., Guy, R., Hogan, T., Kaldor, J, M., Karimi, M., Limnios, A., Regan, D, G., Ryder, N., Su, J, Y., Ward, J. & Lahra, M. M. (2017). Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia. Emerging infectious diseases, 23(9), 1478.
World Health Organization. (2014). Antimicrobial resistance: global report on surveillance. World Health Organization.
Wind, C. M., Bruisten, S. M., van der Loeff, M. F. S., Dierdorp, M., de Vries, H. J., & van Dam, A. P. (2017). A case-control study of molecular epidemiology in relation to azithromycin resistance in Neisseria gonorrhoeae isolates collected in Amsterdam, the Netherlands, between 2008 and 2015. Antimicrobial agents and chemotherapy, 61(6).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Dakson Douglas Araújo; Emanuele Cristina da Silva; Higinalice da Silva Pereira; Maria Valdirene Sampaio do Nascimento; Maristella Pereira dos Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
